ArrePath, Inc.

About ArrePath, Inc.

ArrePath is a company focused on discovering novel small molecule therapeutics to address unmet medical needs using an AI/ML platform that is significantly more efficient than traditional drug discovery approaches. Their mission involves combining human intelligence with advanced data integration to navigate the vast molecular universe and optimize multiple properties simultaneously.

Products & Services

AI/ML Drug Discovery Platform:A platform that leverages AI and machine learning to identify new compounds with progressible attributes, being at least 3X more efficient than traditional methods by integrating data across assays and evaluating models in real-world scenarios.

Antibiotics:Two classes of antibiotics against common bacterial pathogens, each with a novel mechanism of action.

NTM Compounds:Multiple compound families active against Non-Tuberculous Mycobacteria (NTM).

Respiratory Medicine Solutions:Pathways to expand the platform into other therapeutic areas, starting with respiratory medicine.

Specialties

AI/ML in Drug Discovery Small Molecule Therapeutics Antibiotics Development Respiratory Medicine

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 1300000 MR: - FA: £1 million FAN: 1300000	D: 2024-11-19 FD: 2024-11-19	1 investors

Grant Latest

2024-11-19

$1.3M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Kevin Krause

President and Chief Executive Officer

A

Alita Miller

Chief Scientific Officer

K

Kurt Thorn

Chief Technology Officer

Z

Zemer Gitai

Founder and SAB Chair

D

Diego Miralles

Chairman of the Board

D

Dylan Morris

Managing Director, Insight Partners

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

ArrePath, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised